LOGIN  |  REGISTER
Astria Therapeutics

AMN Healthcare Launches Executive Advisory Board

July 31, 2024 | Last Trade: US$39.67 0.26 0.66

DALLAS, July 31, 2024 (GLOBE NEWSWIRE) -- AMN Healthcare (NYSE: AMN) is taking steps to further strengthen its market-leading approach to total talent solutions in healthcare by creating a new Executive Advisory Board, which will be led by Mike Butler, former President of Providence.  

Consisting of accomplished leaders from various healthcare organizations, the Executive Advisory Board will serve as trusted advisors, leveraging their extensive industry expertise to unlock new market opportunities. Their work will center on ways to help healthcare organizations optimize their workforce planning and management. By deploying predictive analytics and workforce expertise, for example, healthcare organizations can determine the right mix of core, contingent, and flexible staff to help manage their costs and deliver excellent care to patients.   

“The formation of our Executive Advisory Board represents another step in our commitment to helping healthcare organizations with innovative workforce solutions that improve patient care and access to quality healthcare,” said Cary Grace, President and CEO of AMN Healthcare. “Mike’s expertise and insights will be invaluable as we navigate the evolving healthcare landscape.” 

Butler brings more than two decades of strategic and operational experience in healthcare. At Providence, he led the organization to unprecedented growth, expanding from a $2 billion organization to $25 billion. His leadership in clinical services, technology solutions, consumer experience, and talent development has been instrumental in shaping the healthcare landscape. He is focused on the future of healthcare and is working with Morningside Ventures and Welsh Carson Anderson Stowe, and he is providing board service to Leiters Health, Enablecomp, League, Prescryptive, Cognoa and Linus Health.  

“I am honored to join AMN Healthcare in shaping the future of workforce management in healthcare,” Butler said. “The healthcare system faces structural labor challenges to meet the nation’s needs, and the Executive Advisory Board aims to empower AMN Healthcare to optimize total talent planning and management, ensuring sustainable clinical workforces.” 

The healthcare industry is facing labor shortages, the need for greater visibility and control in a dynamic labor market, and the necessity for strong partnerships between healthcare organizations and their talent solutions providers. AMN Healthcare is committed to addressing these challenges through technology-enabled solutions and expert guidance from its newly formed Executive Advisory Board. 

About AMN Healthcare 

AMN Healthcare is the leader and innovator in total talent solutions for healthcare organizations across the United States. Through a steadfast partnership approach, we solve the most pressing workforce challenges to enable better clinical outcomes and access to care. We provide a comprehensive network of quality healthcare professionals and deliver a fully integrated and customizable suite of workforce technologies. For more information, visit www.amnhealthcare.com

Media Contact
Corporate Communications
AMN Healthcare
This email address is being protected from spambots. You need JavaScript enabled to view it.
Investor Contact
Randle Reece
Senior Director, Investor Relations & Strategy
AMN Healthcare
(866) 861-3229
This email address is being protected from spambots. You need JavaScript enabled to view it.


C4 Therapeutics

Stock Quote

Featured Stock

Chimerix

Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....

CLICK TO LEARN MORE

Featured Stock

Terns Pharmaceuticals

Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB